Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016

Cromos Pharma’s CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics

Cromos Pharma’s CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics, a biotechnology-based pharmaceutical company focused on the development and commercialization of novel ‎cancer treatments.

CONTACT

INQUIRY@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.

OUR PUBLICATIONS

Debating the Role of Interchangeability in Biosimilar Development
Debating the Role of Interchangeability in Biosimilar Development
Clinical Research Focus 20th Edition September | Cromos Pharma
Clinical Research Focus. 20th Edition
EMA Releases a Reflection Paper on the Role of AI in Drug Development
EMA Releases a Reflection Paper on the Role of AI in Drug Development
Regulatory Landscapes of GMO Research Programs | Cromos Pharma
Cromos Pharma Contemplates Complex International GMO Research Program Regulations
Decentralized Clinical Trials | Cromos Pharma
Decentralized Clinical Trials: Balancing the Promise and Pitfalls in Cost, Recruitment, and Patient Satisfaction
Clinical research focus 19th edition
Clinical Research Focus. 19th Edition
diversity in clinical trials
Advancing Clinical Trial Diversity: A Step Towards Equitable Healthcare
Clinical Trials in the Czech Republic: A Prominent Hub for Scientific Discovery and Cost Optimization
old people in cancer clinical trials
Addressing the Underrepresentation of Older Adults in Cancer CT: Advancing Inclusion for Improved Care
Real-World Evidence in Clinical Trials
Regulatory Focus Shifts: Expanding Role of Real-World Evidence for Evaluating New and Expanded Drug Indications
Clinical Research Focus 18th Edition Publication
Clinical Research Focus. 18th Edition
Poland clinical research, clinical trials in Poland
Poland: A Thriving Hub for Biotech Advancements and Clinical Trials
ASCO Key Takeaways, ASCO Annual Meeting, ASCO 2023
Insights from ASCO 2023
Clinical Research Focus. 17th Edition
clinical trials in Baltic countries
Clinical Trials in the Baltic States – Countries’ Profile for 2023
FDA's RTOR Program, FDA Real-Time Oncology Review
The Pros and Cons of the FDA’s Real-Time Oncology Review Program
Cromos Pharma's Newsletter: Clinical Research Focus
Clinical Research Focus. 16th Edition
Clinical Trials in Hungary
Clinical Trials in Hungary – Country Profile for 2023
News Digest 15. Clinical Research Focus
Clinical Research Focus. 15th Edition
clinical research in bulgaria, Bulgaria clinical trials
Clinical Trials in Bulgaria – Country Profile for 2023
News Digest Edition 14
Clinical Research Focus. 14th Edition
Clinical Trials in Romania, full article on clinical trials in Romania, clinical research, romanian clinical research
Clinical Trials in Romania – So Much to be Discovered
animal testing, use of animals in clinical trials, animal testing in clinical research
Phasing out of Animal Testing for Next Generation Drugs
News Digest Edition 13
Clinical Research Focus. 13th Edition
News Digest Edition 12
Clinical Research Focus. 12th Edition
News Digest on Biotech & Pharma Industry #11 | Cromos Pharma
Clinical Research Focus. 11th Edition
clinical trials in Serbia, clinical research in Serbia, CRO in serbia, clinical trials in Serbia statistics, data on clinical trials in Serbia
Serbia – a land of opportunity for clinical research
News Digest on Biotech & Pharma Industry #10 | Cromos Pharma, clinical trials news, recent clinical trials
Clinical Research Focus. 10th Edition
rare diseases cro, clinical research of rare diseases, challenges in clinical research of rare diseases, future of rare diseases clinical trials
The Not so Rare “Rare” Diseases
clinical research in Türkiye, clinical research in Turkey, CRO in Turkey, number of clinical trials in turkey
Türkiye – a Hidden Gem in Clinical Research